Loading asset research
Nexentis Technologies Inc. Common Stock
NXTSNasdaq · USD · StocksQuote as of · Exchange session not verified$1.62
-4.14%
Today
NXTS
Loading 1D prices…
Market cap
$2.4M
Volume
7.3K
52w high
$52.6752w low
$1.43Company profile
Nexentis Technologies Inc. Common Stock
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Ness Ziona, NY, United States
Employees
7
Fiscal year end
1231
CIK
1789192
Session & valuation
Open$1.63
Previous close$1.69
Day high$1.64
Day low$1.55
30-day avg. volume39K
Outstanding shares1.5M
Diluted EPS-$8.61
Latest annual period
P/E (trailing)0.21
P/E (forward)—
Price / book1.24
Beta1.87
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| BTAIBioXcel Therapeutics Inc. Common Stock | $2.3M | $642K | -10887.38% | -$5.73 | +2.00% | Buy |
| OGENOragenics Inc. Common Stock | $2.2M | $0.00 | — | -$4.56 | -4.40% | Unrated |
| PPCBPropanc Biopharma Inc. Common Stock | $2.1M | $0.00 | — | -$23.82 | -2.34% | Unrated |
| SHPHShuttle Pharmaceuticals Holdings Inc. Common Stock | $2.1M | $0.00 | — | -$7.16 | 0.00% | Unrated |
| MTNBMatinas Biopharma Holdings Inc. Common Stock | $2.7M | $0.00 | — | -$2.00 | -9.76% | Unrated |